| CTRI Number |
CTRI/2024/11/076737 [Registered on: 13/11/2024] Trial Registered Prospectively |
| Last Modified On: |
05/12/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Other |
|
Public Title of Study
|
Evaluation of drugs hyperbaric levobupivacaine and hyperbaric ropivacaine for infra umbilical surgeries under spinal anesthesia. |
|
Scientific Title of Study
|
A comparative evaluation of hyperbaric levobupivacaine and hyperbaric ropivacaine for elective infra umbilical surgeries under spinal anaesthesia: A randomized trial. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Suhas Kumar Mall |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences. Gorakhpur. |
| Address |
Trauma and Emergency Medicine Department.
All India Institute of Medical Sciences.
Kunraghat. Gorakhpur. Uttar Pradesh.
Gorakhpur UTTAR PRADESH 273008 India |
| Phone |
8238038707 |
| Fax |
|
| Email |
drsuhasmall@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Suhas Kumar Mall |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences. Gorakhpur. |
| Address |
Trauma and Emergency Medicine Department.
All India Institute of Medical Sciences.
Kunraghat. Gorakhpur. Uttar Pradesh.
Gorakhpur UTTAR PRADESH 273008 India |
| Phone |
8238038707 |
| Fax |
|
| Email |
drsuhasmall@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Suhas Kumar Mall |
| Designation |
Assistant Professor |
| Affiliation |
All India Institute of Medical Sciences. Gorakhpur. |
| Address |
Trauma and Emergency Medicine Department.
All India Institute of Medical Sciences.
Kunraghat. Gorakhpur. Uttar Pradesh.
Gorakhpur UTTAR PRADESH 273008 India |
| Phone |
8238038707 |
| Fax |
|
| Email |
drsuhasmall@gmail.com |
|
|
Source of Monetary or Material Support
|
| All India Institute of Medical Sciences. kunraghat,Gorakhpur, Uttar Pradesh. 273008 |
|
|
Primary Sponsor
|
| Name |
Dr Suhas Kumar Mall |
| Address |
Trauma and Emergency Medicine Department. All India Institute of Medical Sciences. Kunraghat, Gorakhpur.273008. Uttar Pradesh |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Suhas Kumar Mall |
All India Institute of Medical Sciences. Gorakhpur. |
Ground Floor, Trauma and Emergency Medicine Department. Gorakhpur UTTAR PRADESH |
8238038707 - drsuhasmall@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Human Ethics Committee. All India Institute of Medical Sciences. Gorakhpur. UP. |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: 8||Other Procedures, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
0.5%% hyperbaric levobupivacaine and 0.5% hyperbaric ropivacaine |
Patients Group R will receive intrathecal((Subarachnoid block) dose of 15mg (3 ml) of 0.5% hyperbaric ropivacaine.observation up to 24 hours |
| Intervention |
Elective infra-umbilical surgeries under spinal anesthesia |
Patient Group L will receive intrathecal(Subarachnoid block) dose of 15mg (3 ml) of 0.5% hyperbaric levobupivacaine. observation up to 24 hours. |
|
|
Inclusion Criteria
|
| Age From |
25.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
a) Patients of the American Society of Anesthesiologists I, II, and III.
b) Weight 40-80 kg
c) Elective infra umbilical surgeries of approximately 2 ½ hrs.
d) Patients who have given informed written consent.
|
|
| ExclusionCriteria |
| Details |
a) Patient refusal.
b) Infection.
c) Coagulopathy.
d) LSCS.
e) Spinal deformity.
f) Patients of American Society of Anesthesiologists IV.
g) Allergic to local anesthetic drugs.
h) H/O seizures and neurological deficit.
i) Severe renal, hepatic, respiratory and cardiovascular disease.
j) Lack of informed written consent.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To determine the time to onset of sensory block, time to peak sensory block and duration of sensory block. |
Time to onset of sensory and motor block after giving drug. Time of duration of sensory and motor block till the next 24 hours and intraoperative hemodynamic monitoring every 1,3,5,10,15 mins and then every 15mins for the next 2 hours.
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
(a) To determine the time to onset of sensory block, time to peak sensory block & duration of sensory block.
(b) To determine the time to complete motor block & duration of motor block.
(c) To determine the duration of analgesia.
(d) Intraoperative haemodynamics.
(e) Postoperative recovery profile.
(f) Complications (If Any )
|
Time to onset of sensory & motor block after giving drug. Time of duration of sensory & motor block till the next 24 hours & intraoperative hemodynamic monitoring every 1,3,5,10,15 mins & then every 15mins for the next 2 hours. |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
18/11/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
Modification(s)
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
Modification(s)
|
Spinal anaesthesia is an easy inexpensive and preferable technique for elective below umbilical surgeries. This study will compare the clinical effect, safety, and postoperative recovery profile of hyperbaric levobupivacaine and hyperbaric ropivacaine for elective below umbilical surgeries under Spinal anaesthesia. We will determine the time to onset of sensory block, time to peak sensory block, duration of sensory block, time to complete the motor block, duration of the motor block, duration of analgesia, intraoperative hemodynamic, postoperative recovery profile and Complications (If Any ). It’s a Prospective, randomized and comparative study of duration of 2 years, conducted at patients coming to All India Institute of Medical Sciences, Gorakhpur, which falls in the inclusion criteria. All samples collected during the above-mentioned period will be included in this study. Minimum of 60 patients; 30 in each group. Patients will be divided into: GROUP R: Patients in this group received intrathecal 15 mg (3 ml) of 0.5% hyperbaric Ropivacaine. GROUP L: Patients in this group received intrathecal 15 mg (3 ml) of 0.5% hyperbaric Levobupivacaine. Patients will be given drugs as per the opening of the envelope and after following the standard protocol of consent, attaching a multipara monitor and aseptic measure, spinal is given. The objectives will be measured at a specific time duration and patient data will be documented in the specified group. The data will be compared and the conclusion and discussion will be made as per the available results. |